Pipeline Pharmacological Therapies in Clinical Trial for COVID-19 Pandemic: a Recent Update

The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), responsible for causing coronavirus disease 2019 (COVID-19), marked the third time in the twenty-first century when a new, highly pathogenic human coronavirus outbreak has led to an epidemic. The COVID-19 epidemic has...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumari, Puja, Rawat, Kajal, Saha, Lekha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Covid-19 (ATY Lau and A Kong, Section Editors)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367788/
https://www.ncbi.nlm.nih.gov/pubmed/32837854
http://dx.doi.org/10.1007/s40495-020-00226-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367788/
https://www.ncbi.nlm.nih.gov/pubmed/32837854
http://dx.doi.org/10.1007/s40495-020-00226-5

Ejemplares similares